This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rounbehler, R. J. Articles by Johnson, D. G. Search for Related Content PubMed PubMed Citation Articles by Rounbehler, R. J. Articles by Johnson, D. G.

Inactivation of E2f1 Enhances Tumorigenesis in a Myc Transgenic Model¹

Department of Carcinogenesis, Science Park-Research Division, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957

Previous studies have demonstrated both oncogenic and tumor suppressive properties for the E2F1 transcription factor. In this study, E2f1-null mice were crossed with transgenic mice expressing Myc under the control of an epithelial-specific keratin 5 promoter to determine whether the absence of E2F1 would modulate the oncogenic activity of Myc. Inactivation of E2f1 was found to significantly accelerate tumor development in keratin 5 Myc transgenic mice. Acceleration of tumorigenesis occurred despite the fact that apoptosis levels were increased in transgenic tissue and tumors null for E2f1, whereas Myc-induced proliferation was unaffected by the status of E2f1. These findings provide new insight into the tumor suppressive activity of E2F1 and identify for the first time a specific oncogenic alteration that cooperates with the loss of E2F1 in tumorigenesis.

This article has been cited by other articles:

				M. Gu, R. P. Singh, S. Dhanalakshmi, S. Mohan, and R. Agarwal Differential effect of silibinin on E2F transcription factors and associated biological events in chronically UVB-exposed skin versus tumors in SKH-1 hairless mice. Mol. Cancer Ther., August 1, 2006; 5(8): 2121 - 2129. [Abstract] [Full Text] [PDF]

				R. V. Pusapati, R. J. Rounbehler, S. Hong, J. T. Powers, M. Yan, K. Kiguchi, M. J. McArthur, P. K. Wong, and D. G. Johnson ATM promotes apoptosis and suppresses tumorigenesis in response to Myc PNAS, January 31, 2006; 103(5): 1446 - 1451. [Abstract] [Full Text] [PDF]

				P. L. Miliani de Marval, E. Macias, R. Rounbehler, P. Sicinski, H. Kiyokawa, D. G. Johnson, C. J. Conti, and M. L. Rodriguez-Puebla Lack of Cyclin-Dependent Kinase 4 Inhibits c-myc Tumorigenic Activities in Epithelial Tissues Mol. Cell. Biol., September 1, 2004; 24(17): 7538 - 7547. [Abstract] [Full Text] [PDF]

				B. Scheijen, M. Bronk, T. van der Meer, D. De Jong, and R. Bernards High Incidence of Thymic Epithelial Tumors in E2F2 Transgenic Mice J. Biol. Chem., March 12, 2004; 279(11): 10476 - 10483. [Abstract] [Full Text] [PDF]

				M. M. Simile, M. R. De Miglio, M. R. Muroni, M. Frau, G. Asara, S. Serra, M. D. Muntoni, M. A. Seddaiu, L. Daino, F. Feo, et al. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells Carcinogenesis, March 1, 2004; 25(3): 333 - 341. [Abstract] [Full Text] [PDF]

				Y. Li, X. Sun, J. T. LaMont, A. B. Pardee, and C. J. Li Selective killing of cancer cells by beta -lapachone: Direct checkpoint activation as a strategy against cancer PNAS, March 4, 2003; 100(5): 2674 - 2678. [Abstract] [Full Text] [PDF]